...
首页> 外文期刊>Medical Devices: Evidence and Research >Novel uterine lavage system for recovery of human embryos fertilized and matured in vivo
【24h】

Novel uterine lavage system for recovery of human embryos fertilized and matured in vivo

机译:新型子宫灌洗系统,可回收体内受精和成熟的人类胚胎

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: In this paper we describe a novel uterine lavage system for the recovery of in vivo preimplantation embryos. Currently, no other method exists to retrieve preimplantation embryos except for in vitro fertilization (IVF). Methods: A single center, prospective feasibility study was conducted to test a novel uterine lavage system for the recovery of in vivo preimplantation embryos in egg donors and patients seeking pregnancy. Subjects were placed on controlled ovarian hyperstimulation followed by intrauterine insemination (IUI) and uterine lavage performed approximately 4–6 days after IUI. Subjects were followed up for 30 days after the procedure to monitor for safety events. Results: A total of 134 uterine lavage cycles were performed on 81 subjects (average: 1.7 cycles/subject). Ova (oocytes or embryos) were collected in 53% (71/134) of the cycles with steady improvement of recovery efficiency over the course of the study, and embryos collected in 42% (56/134) of cycles. Embryos of many stages were collected, but 71% (96/136) of embryos collected were blastocyst stage embryos which are at the most advanced stage of embryogenesis. Embryos recovered were of good quality based on blastocyst gradings in which 74% (70/95, 1 blastocyst not graded) of the blastocysts were good quality as determined by the Gardner Scale of Morphology. The procedure was well tolerated with minor side effects. In 8% of cycles a positive hCG was observed after the lavage indicating some embryos were not recovered by the lavage system. Conclusion: Through this work the system has been shown to recover embryos from the uterus in a safe and effective manner, thus opening the possibility that uterine lavage may serve as an alternative to IVF where patient indications allow.
机译:目的:在本文中,我们描述了一种用于体内植入前胚胎恢复的新型子宫灌洗系统。目前,除体外受精(IVF)之外,没有其他方法可以恢复植入前的胚胎。方法:进行了一项单中心前瞻性可行性研究,以测试一种新型的子宫灌洗系统,以恢复卵子供体和寻求妊娠患者体内植入前的胚胎。将受试者置于受控的卵巢过度刺激下,然后进行宫内授精(IUI),并在IUI后约4-6天进行子宫灌洗。手术后对受试者进行了30天的随访,以监测安全事件。结果:共对81位受试者进行了134次子宫灌洗周期(平均:1.7个周期/受试者)。在研究过程中,以53%(71/134)的周期收集卵(卵母细胞或胚胎),回收效率稳定提高,而在研究周期中42%(56/134)收集胚胎。收集了多个阶段的胚,但是收集到的胚中有71%(96/136)是胚泡期胚,处于胚发生的最晚期。根据囊胚等级,回收的胚胎具有良好的质量,其中根据Gardner形态学评分法,其中74%(70 / 95,1个未分级的囊胚)具有良好的质量。该程序耐受良好,副作用较小。灌洗后,在8%的周期中观察到hCG阳性,表明某些胚胎无法通过灌洗系统恢复。结论:通过这项工作,该系统已被证明可以安全有效地从子宫中回收胚胎,因此在患者适应症允许的情况下,有可能子宫灌洗可以代替IVF。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号